Washington State Department of Health Hep C Free Washington [AASLD WEBINAR TODAY] IMPACT OF COVID-19 ON GLOBAL ELIMINATION OF VIRAL HEPATITIS: THE US PERSPECTIVE

WEBINAR

Impact of COVID-19 on Global Elimination of Viral Hepatitis: The US Perspective

Thursday, October 22, 2020

5:00pm-6:00pm ET (2:00-3:00pm PT)

Register HERE

 

CONTENT CONTRIBUTORS

American Association for the Study of Liver Diseases

AASLD COVID-19 Clinical Oversight Subcommittee

PRESENTERS

• Natasha Martin, PhD
  University of California, San Diego
• Don C Des Jarlais, PhD
  New York University
• David L. Thomas, MD
  Johns Hopkins University School of Medicine

MODERATOR

• John W. Ward, MD
  Coalition for Global Hepatitis Elimination

PANELISTS

• Nancy Reau, MD, FAASLD
  Rush University Medical Center
• Andrew Reynolds
  San Francisco AIDS Foundation

DETAILS

As COVID-19 has had a profound impact on the entire health care system, COVID-19 has also had a major impact on goal of global elimination of viral hepatitis.

This webinar will:

• Discuss the impact of SARs-CoV-2 on the viral care cascade
• Identify services disrupted by COVID19 that will impact the future of HCV elimination in the US
• Outline innovative alternatives to minimize the influence of COVID19 on viral hepatitis elimination

Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, October 20, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.